This episode exposes how pharmaceutical giants profit from sickness by controlling drug patents, inflating prices, and prioritizing marketing over medical ethics. It explains how taxpayer-funded research is often privatized for corporate gain, and how monopolies prevent access to affordable treatment. Using the opioid crisis as a case study, the episode highlights how profit-driven strategies can lead to mass harm. Ultimately, it argues that healthcare has become a business first and a service second—and questions whether life-saving medicine should belong in the hands of private corporations.